Kelt, I would guess the program on hold that he may restart is oral delivery of B. That could be a fairly inexpensive program and if successful would increase Big Pharma interest geometrically. JMHO
(3)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links